About the 3rd Annual Neuroscience Innovation Forum
Building on the success of our 2nd Annual NIF we are pleased to announce our 3rd Annual Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology to take place at the Marines' Memorial Club, San Francisco on the 12th of January 2020, a day before the JP Morgan meeting.
The program will cover BioPartnering for CNS, with industry keynotes and panels on AD, PD, Neuropsychiatry and Pain Management. Moreover, there are panels on innovation in NeuroTech covering banking, device, diagnostics and software.
The target audience are buy and sell side analysts from investment banks and funds and partnering executives from pharma, biotech and medtech companies. We anticipate over 250 delegates and 30+ company presentations by established listed, private and emerging companies.
There are numerous networking opportunities available via an online One-2-One meeting system with dedicated meeting facilities to make the event more transactional.
Plenary & Therapeutic Sessions will Include:
Confirmed Keynote Speeches by:
Confirmed Speakers & Chairs Include:
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business.
Presenting Companies in 2020 Forum Include:
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.
Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.
To learn more about presenting, exhibition or sponsorship opportunities, please contact:
Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia
Participating Pharmas Include:
Investors & Analysts Attending:
5AM Venture Management LLC
Aisling Capital LLC
Alta Global Ventures
Aqua Partners, LLC
Arch Venture Partners
Bay City Capital, LLC
BOHE Angel Fund
Boltendahl International Partners
Brookline Capital Markets
Capricorn Partners NV
CTI Life Sciences
Dolby Family Ventures
Dorset Capital LLC
Excellentia Global Partners
Fraser Finance LLP
Global Neurohealth Ventures
H. Lundbeck A/S
H.C. Wainwright & Co., LLC
Health Passion Fund
High-Tech Gründerfonds Management GmbH
Inkef Capital B.V.
Ladenburg, Thalmann & Co., Inc.
Life Science Angels
LifeArc Seed Fund
Mitsui & Co. Global Investment, Ltd.
MPM Capital, Inc.
New Enterprise Associates (NEA)
New Harbor Venture Partners, LLC
Novo Holdings A/S
Oppenheimer & Co. Inc.
OrbiMed Advisors LLC
Panakes Partners SBMT SpA
Partner's Innovation Fund
Qiming Venture Partners
Sand Hill Angels
Stifel Financial Corp.
The Michael J. Fox Foundation for Parkinson's Research
Toscana Ventures, LLC
View Full List